NCT02370121View on ClinicalTrials.gov

Effect of Gymnema Sylvestre on Metabolic Syndrome and Insulin

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

January 31, 2015

Conditions
Metabolic Syndrome
Interventions
DRUG

Placebo

Capsules of 300 mg two times per day before breakfast and dinner a total dose of 600 mg per day. During 90 days.

DRUG

Gymnema Sylvestre

Capsules of 300 mg of calcined magnesium two times per day before breakfast and dinner a total dose of 600 mg per day. During 90 days.

All Listed Sponsors
lead

University of Guadalajara

OTHER

NCT02370121 - Effect of Gymnema Sylvestre on Metabolic Syndrome and Insulin | Biotech Hunter | Biotech Hunter